* Ultralife Corp ULBI.OQ reported a quarterly adjusted
loss of 6
cents per share for the quarter ended in December. The lone
analyst forecast for the quarter was for a loss of 4 cents per
share.
* Revenue was $23.76 million; analysts expected $21.00
million.
* Ultralife Corp's reported EPS for the quarter was a loss
of 7
cents.
* The mean earnings estimate of analysts had fallen by
about 130.8% in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Ultralife Corp shares had fallen by 10.4% this quarter.
* The company reported a quarterly loss of $1.13 million.
* Wall Street's median 12-month price target for Ultralife
Corp is
$12.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated February 3 at 02:31 p.m.
All figures in US dollars unless otherwise stated